This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Microsoft Downplays Facebook Rumors

Editor's note: In this feature from Stockpickr, we highlight lists of stocks that have been upgraded by analysts, are experiencing activist situations or some other market-moving events.

Rumors of the Day: Microsoft (MSFT - Get Report) CEO Steve Ballmer played down speculation it is interested in buying a stake in the privately held social networking site Facebook, according to Bloomberg. While Ballmer said Microsoft is "delighted" to partner with Facebook on advertising sales, "everything else" is just "idle speculation." Microsoft was flat at $29.77.

Today's Hot List: Canada's TD Bank (TD - Get Report) acquired Commerce Bancorp (CBH) for $8.5 billion in cash and stock. Under the agreement, Commerce shareholders will receive 0.4142 TD common shares and $10.50 in cash in exchange for each common share of Commerce, based on Commerce's roughly $42 per share closing price on Oct. 1. Commerce shares slipped 17 cents to $39.44.

Palm (PALM) beat first-quarter estimates by a penny, reporting earnings of 9 cents a share. The company reported revenue of $360.8 million, vs. the consensus of $360.3 million. The company sees second-quarter earnings of between 6 cents a share and 8 cents a share, compared to the consensus of 10 cents a share. The handheld device maker expects second-quarter revenue of between $370 million and $380 million, vs. Wall Street's expectations of $413.5 million. Shares are down 57 cents to $15.43.

Analyst Downgrades: Deutsche Bank downgraded CBS (CBS - Get Report) to hold from buy. The bank cited soft ratings trends and poor local ad growth. Deutsche Bank lowered its price target to $33. Shares fell 22 cents at $30.84.

Analyst Upgrades: Wachovia upgraded biotech concern PDL Biopharma (PDLI - Get Report) to outperform from market perform. CEO Mark McDade is stepping down under pressure and the company is for sale. The bank said the stock could command $24 to $25 a share. Shares surged $1.85, or 8.7%, to $23.22.

Latest Activist Situations: In an amended regulatory filing, Strongbow Capital said discount retailer Duckwall-ALCO Stores (DUCK) should expand the size of its board by one member and appoint Royce Winsten to fill the newly created position. It also said the company should create an executive committee of the board, which would be authorized to exercise all the powers and authority of the board in managing the company. The firm, which owns 14.2% of Duckwall, said the executive committee would oversee a reduction in average inventory levels and losses from shrinkage. Duckwall was sinking 55 cents at $36.19.

Stockpickr is a wholly owned subsidiary of

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
CBS $62.80 0.00%
MSFT $43.28 0.00%
PDLI $7.02 0.00%
TD $43.40 0.00%
AAPL $129.36 0.00%


DOW 18,203.37 -85.26 -0.47%
S&P 500 2,107.78 -9.61 -0.45%
NASDAQ 4,979.9010 -28.1950 -0.56%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs